Liberty Latin America Ltd.
8.65USD
-0.0400 (-0.46%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $-0.09▼ | $0 | 0 | 0 |
| Next quarter | $-0.01▼ | $0 | 0 | 0 |
| Current year | $-0.1▼ | $0.41 | 0 | 1 |
| Next year | $0.2▼ | $0.72 | 0 | 1 |
Beat in 1 of the last 1
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2025-09-30 | $-0.06 | $0.02 | +0.08 (+133.3%) |
39 ratings from 11 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Morgan Stanley | Downgraded from Equal-Weight | Underweight | $7 | Aug 20, 2026 |
| Benchmark | Maintained | Buy | $12 $13 | Nov 10, 2025 |
| Barclays | Downgraded from Equal-Weight | Underweight | $8 $6.5 | Feb 25, 2025 |
| Goldman Sachs | Maintained | Buy | $8.4 $9.3 | May 28, 2024 |
| Goldman Sachs | Maintained | Buy | $8.4 $9.3 | May 22, 2024 |
| Barclays | Maintained | Equal-Weight | $9 $8 | May 7, 2024 |
| Scotiabank | Upgraded from Sector Underperform | Sector Perform | — | Sep 27, 2023 |
| Barclays | Maintained | Equal-Weight | $9.5 $9.25 | Aug 31, 2023 |
| Goldman Sachs | Initiated | Buy | $10 | May 31, 2023 |
| Barclays | Maintained | Equal-Weight | $11 $10.5 | May 9, 2022 |
| Morgan Stanley | Downgraded from Overweight | Equal-Weight | $14 $15 | Apr 16, 2021 |
| Scotiabank | Downgraded from Sector Perform | Sector Underperform | $6.5 | Nov 5, 2020 |
| Goldman Sachs | Upgraded from Neutral | Buy | $15 | Oct 9, 2020 |
| Morgan Stanley | Upgraded from Equal-Weight | Overweight | — | Oct 9, 2020 |
| Benchmark | Maintained | Buy | $20 $17 | Apr 21, 2020 |
| HSBC | Upgraded from Hold | Buy | $17.5 | Mar 12, 2020 |
| Benchmark | Maintained | Buy | $26 $24 | Nov 15, 2019 |
| Barclays | Maintained | Equal-Weight | $20 $19.5 | Nov 13, 2019 |
| Barclays | Upgraded from Underweight | Equal-Weight | — | Oct 17, 2019 |
| Benchmark | Initiated | Buy | $26 | Jul 25, 2019 |
| Buckingham Research | Maintained | Buy | $30 $28 | Aug 16, 2018 |
| Morgan Stanley | Upgraded from Underweight | Equal-Weight | — | Apr 3, 2018 |
| Barclays | Downgraded from Equal-Weight | Underweight | — | Nov 6, 2017 |
| Barclays | Maintained | Equal-Weight | $25 $24 | Oct 16, 2017 |
| HSBC | Initiated | Reduce | $22.5 | Oct 9, 2017 |
71 filings from 16 insiders · 27 buy / 1 sell over 6m
Officers and directors of LILA, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| DE ANGOITIA ALFONSODirector | Buyindirect | 313.1k | $20.95 | $6.56M | Sep 2, 2026 |
| DE ANGOITIA ALFONSODirector | Buyindirect | 17.6k | $20.65 | $363k | Sep 1, 2026 |
| MALONE JOHN C10% owner; Director Emeritus | Buyindirect | 69.5k | $8.50 | $590k | Sep 1, 2026 |
| DE ANGOITIA ALFONSODirector | Buyindirect | 145.5k | $21.00 | $3.06M | Aug 31, 2026 |
| MALONE JOHN C10% owner; Director Emeritus | Buyindirect | 51.8k | $8.48 | $439k | Aug 28, 2026 |
| MALONE JOHN CDivisional Officer | Buyindirect | 6.8k | $8.50 | $57k | Aug 14, 2026 |
| MALONE JOHN CDivisional Officer | Buyindirect | 50.7k | $8.50 | $431k | Aug 13, 2026 |
| MALONE JOHN CDivisional Officer | Buyindirect | 127.8k | $8.47 | $1.08M | Aug 10, 2026 |
| PADDICK BRENDAN JOHNDirector | Grant | 1.3k | $7.84 | $10k | Jun 30, 2026 |
| GOULD PAUL ADirector | Grant | 108 | $7.84 | $847 | Jun 30, 2026 |
| DE ANGOITIA NORIEGA ALFONSODirector | Grant | 1.2k | $7.84 | $10k | Jun 30, 2026 |
| MALONE JOHN CDirector | Buy | 354.4k | $6.96 | $2.47M | Jun 26, 2026 |
| MALONE JOHN CFormer | Buy | 1.50M | $4.98 | $7.82M | Jun 23, 2026 |
| PADDICK BRENDAN JOHNDirector | Buy | 100.0k | $4.88 | $488k | Jun 18, 2026 |
| MALONE JOHN CFormer | Sellindirect | 61.1k | $8.63 | $527k | May 22, 2026 |
| MALONE JOHN CFormer | Buy | 61.1k | $8.63 | $527k | May 22, 2026 |
| PADDICK BRENDAN JOHNDirector | Grant | 958 | $8.64 | $8k | Mar 31, 2026 |
| GOULD PAUL ADirector | Grant | 93 | $8.64 | $804 | Mar 31, 2026 |
| DE ANGOITIA NORIEGA ALFONSODirector | Grant | 976 | $8.64 | $8k | Mar 31, 2026 |
| SANCHEZ DANIEL EDirector | Other | 7.5k | — | — | Mar 13, 2026 |
No analyst notes on LILA yet.
Analyst Ratings
4 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 0 | 2 | 1 | 1 | 0 | Hold2.75 |
| 1 mo ago | 0 | 2 | 0 | 1 | 0 | Hold2.67 |
| 2 mo ago | 0 | 2 | 1 | 0 | 0 | Buy2.33 |
| 3 mo ago | 0 | 2 | 1 | 0 | 0 | Buy2.33 |